Member Info for doggo

https://twitter.com/greenhamneggs/status/1473993212050427905?s=21

Indeed

We need the liquidity

Tara Stacom, Executive Vice Chair, Cushman & Wakefield. “Real estate is a $300 trillion-plus addressable market suffering from virtually the same data processing, transactional, and valuation issues that have challenged the industry for decades. Inveniam offers innovative solutions to help solve those very problems.”

“As financial conditions continue to drive interest in private market investment, our board members who are globally recognized leaders in real estate, fund administration, financial markets, and technology will assist us as we grow and continue to build the technology that not only solves private market pain points but will be a catalyst for dramatically growing those markets,” said Pat O’Meara, Chairman and CEO of Inveniam.

The announcement of the board comes as Inveniam surpasses $5 billion in AOP.

https://twitter.com/greenhamneggs/status/1473684118034599950?s=21

Changed from Eurox Group GmbH to Eurox Group AG.
In other words... conversion into the legal form of a stock corporation

Hello ladies

Waiting for this Eurox one. Significant name change to Eurox Group AG...

Big unit. Well done Leap.

Shocking news for Leap. Disappointed they’ve got another deal.

We hit 15p on the day of this RNS...we now hold 350% more.

FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to note that Little Green Pharma Ltd ('LGP') has today announced that it will be exclusively supplying medicinal cannabis oil products to enrolled patients as well as providing funding for study costs for the QUality of life Evaluation STudy ("The QUEST Initiative"). The QUEST Initiative, which is being conducted by researchers at the University of Sydney, aims to be one of the world's largest longitudinal studies investigating the quality of life and health economics on patients with chronic disease prescribed medicinal cannabis. FastForward has a 0.9% interest in the issued stock of LGP.

Come on list the negatives from the investee companies this year...

I’ll wait

Same question form Midas & Barwick. List all the negatives from the last 12 months.

Give us all the negatives from the last 12 months YNWA for balance...

Anyone buying at 7p last year had ample chance to sell at a bag or more this year. The previous year anyone wig bought at 5 could have sold at 12...
Midas I’ve been telling people to sell ifctyrt were not happy from 13p this year...

I’ll eat a barwick pie if Eurox isn’t valued by the BOD at over €6 million NOW

We are an investment vehicle with a portfolio of investee companies. So your question needs 2 answers.
You are obviously referring to SP. we were 7.35p a year today. We have traded at more than double this year..

Have any of the investments gone backwards in the year (in terms of what they have achieved in the past 12 months) then obviously the answer is no.

Do we offer more potential than last year? Yes
Are we cheaper than last year? Yes

We don’t like buyers do we gang...grrr

Showing as a sell O’Donnell. Naughty

Irrelevant nonsense

I’ve got you dangling on my line barwick...